3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
5
Colorectal Neoplasms
4
Hematologic Neoplasms
3
Prostatic Neoplasms
2
Motor Activity
2
Lung Neoplasms
2
Hodgkin Disease
2
Hematopoietic and Lymphoid System Neoplasm
2
Carcinoma, Non-Small-Cell Lung
2
Trastuzumab Cardiotoxicity
1
Stress Disorders, Post-Traumatic
1
Sleep Wake Disorders
1
Sedentary Behavior
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Obesity
1
Neoplasms
1
Neoplasm Metastasis
1
Myocardial Fibrosis
1
Multiple Endocrine Neoplasia Type 1
1
Lymphoma, Follicular
1
Insulin Resistance
1
Hereditary Breast and Ovarian Cancer Syndrome
1
Heart Diseases
1
Head and Neck Neoplasms
1
Gastrointestinal Diseases
1
Fatigue
1
Esophageal Neoplasms
1
Dyslipidemias
1
Depression
1
Interventions
Metformin
18
Inositol
5
Exercise
4
Pioglitazone
3
Insulin
3
Ethinyl Estradiol
3
drospirenone and ethinyl estradiol combination
2
Surveys and Questionnaires
2
Cyproterone Acetate
2
Acupuncture Therapy
2
ziprasidone
1
salicylsalicylic acid
1
maltodextrin
1
licogliflozin
1
exendin (9-39)
1
drospirenone
1
cinnulin PF
1
Zoledronic Acid
1
Waist-Hip Ratio
1
Waist Circumference
1
Vitamin D
1
Time
1
Thioctic Acid
1
Tablets
1
Sulfasalazine
1
Sugars
1
Sodium-Glucose Transporter 2 Inhibitors
1
Sodium Salicylate
1
Saline Solution
1
Resistance Training
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Insulin Resistance
×
Exercise Test
×
Clear all
NCT05215223
2023-10-17
WBV
Cairo University
Phase NA
Completed
46 enrolled